CASI PHARMACEUTICALS, INC. (CASI) Files An 8-K Results of Operations and Financial Condition

CASI PHARMACEUTICALS, INC. (CASI) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02Results of Operations and Financial Condition.

On November 14, 2016, CASI Pharmaceuticals, Inc. (the Company)
issued a press release reporting its financial results for the
three and nine month periods ended September 30, 2016. The press
release is furnished as Exhibit99.1 to this Current Report on
Form 8-K.

The information on this Current Report on Form 8-K (including
Exhibit99.1) shall not be deemed filed for purposes of Section18
of the Securities Act of 1934, as amended (the Exchange Act) or
otherwise subject to the liabilities of that Section, nor shall
it be deemed incorporated by reference in any filing by the
Company under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference
in such a filing.

Item 9.01Financial Statements and Exhibits.

(d) Exhibits
99.1 Press Release of CASI Pharmaceuticals, Inc., dated November
14, 2016


About CASI PHARMACEUTICALS, INC. (CASI)


An ad to help with our costs